Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quercetin vs Nano-Quercetin in TSCC Cell Lines
NCT05456022Phase 2Unknown
- Sponsor
- Cairo University
- Start
- Jul 2022
- Primary completion
- Dec 2023
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of quercetin in tongue squamous cell carcinoma, sponsored by Cairo University. Status: unknown.
02
Drugs
quercetin
03
Conditions
tongue squamous cell carcinoma
Beyond the preview
Go deeper on NCT05456022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05456022.